P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension

Autor:	Petersen AnnKatrin, Usiskin Keith, Ghosh Subrata, Liu Wenzhong, Vermeire Severine, Hanauer Stephen, Feagan Brian, D'Haens Geert, Wolf Doug, Charles Lorna, Huang Vivian, Sandborn William
Rok vydání:	2020
Předmět:	Moderate to severe Ozanimod medicine.medical_specialty Hepatology business.industry Gastroenterology MEDLINE medicine.disease Ulcerative colitis chemistry.chemical_compound chemistry Internal medicine Medicine In patient Long term safety Open label business
Zdroj:	The American journal of gastroenterology. 115(Suppl 1)
ISSN:	1572-0241
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d082c6f82b0a11510cb008a61bb9533f https://pubmed.ncbi.nlm.nih.gov/33566505 Zobrazit plný text záznamu